These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Examining Manufacturing Readiness for Breakthrough Drug Development. Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693 [No Abstract] [Full Text] [Related]
3. Deconstructing the drug development process: the new face of innovation. Kaitin KI Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565 [TBL] [Abstract][Full Text] [Related]
5. Affairs of the Heart: Innovation in Cardiovascular Research and Development. Honig P; Terzic A Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903 [TBL] [Abstract][Full Text] [Related]
7. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666 [No Abstract] [Full Text] [Related]
8. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]
9. Closing the drug lag for new drug submission and review in Japan: An industry perspective. Poirier AF Clin Pharmacol Ther; 2015 Nov; 98(5):486-8. PubMed ID: 26239646 [TBL] [Abstract][Full Text] [Related]
10. Eyes on new product development: ophthalmic drug delivery. Novack GD J Ocul Pharmacol Ther; 2013 Mar; 29(2):90-1. PubMed ID: 23485090 [No Abstract] [Full Text] [Related]
11. Challenges of biomarkers in drug discovery and development. Goodsaid F Expert Opin Drug Discov; 2012 Jun; 7(6):457-61. PubMed ID: 22471322 [TBL] [Abstract][Full Text] [Related]
12. An industrial perspective on contemporary applications of PBPK models in drug discovery and development. Smith BJ Biopharm Drug Dispos; 2012 Mar; 33(2):53-4. PubMed ID: 22407480 [No Abstract] [Full Text] [Related]
14. FDA not NIH can speed new drugs. Miller HI Nature; 2011 Apr; 472(7342):169. PubMed ID: 21490657 [No Abstract] [Full Text] [Related]
15. The risky business of drug development in neurology. Craven R Lancet Neurol; 2011 Feb; 10(2):116-7. PubMed ID: 21256451 [No Abstract] [Full Text] [Related]
16. Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology. Rowe-Rendleman CL Pharm Res; 2019 Feb; 36(4):54. PubMed ID: 30790065 [TBL] [Abstract][Full Text] [Related]
18. Virtual drug discovery with the rise of Chinese CROs. Zhang MQ Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343 [No Abstract] [Full Text] [Related]